1459-39-8 Usage
Uses
Used in Pharmaceutical Industry:
Cycloheptanecarboxamide is used as an active pharmaceutical ingredient for the development of analgesic and antipyretic drugs. Its ability to alleviate pain and reduce fever makes it a valuable component in the formulation of medications aimed at improving patient comfort and well-being.
Used in Chemical Synthesis:
Cycloheptanecarboxamide is used as a building block in the synthesis of other organic compounds. Its stable and versatile nature allows it to be incorporated into various chemical reactions, contributing to the creation of new molecules with potential applications in various industries.
Used in Chemical Research:
Cycloheptanecarboxamide is utilized as a research tool in the study of chemical reactions and the development of new synthetic pathways. Its unique structure and properties make it an interesting subject for exploration in the field of organic chemistry, potentially leading to the discovery of novel compounds and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1459-39-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,5 and 9 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1459-39:
(6*1)+(5*4)+(4*5)+(3*9)+(2*3)+(1*9)=88
88 % 10 = 8
So 1459-39-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO/c9-8(10)7-5-3-1-2-4-6-7/h7H,1-6H2,(H2,9,10)
1459-39-8Relevant academic research and scientific papers
Nitrile Hydration Reaction Using Copper Iodide/Cesium Carbonate/DBU in Nitromethane-Water
Kuwabara, Jun,Sawada, Yoshiharu,Yoshimatsu, Mitsuhiro
supporting information, p. 2061 - 2065 (2018/09/14)
The catalytic nitrile hydration (amide formation) in a copper iodide/cesium carbonate/1,8-diazabicyclo[5.4.0]undec-7-ene/nitromethane-water system is described. The protocol is robust and reliable; it can be applied to a broad range of substrates with high chemoselectivity.
Organic compounds substituted heptadeca-5,9- and 5,10-dienoic acid
-
, (2008/06/13)
The present invention provides novel substituted heptadeca-5,9- and 5,10-dienoic acid and similar fatty acid compounds which are derivatives of certain prostaglandins and are potent thromboxane A2 inhibitors. By virtue of this pharmacological property, they represent useful pharmacological agents for a wide variety of purposes.
